CV 205-502 is a new dopamine agonist used for hyperprolactinaemia. We
report a case of acute overdose (one month treatment, i.e. 2.25 mg) in
a 25-year-old male patient. Clinical symptoms were restricted to naus
ea and mild hypotension. Treatment consisting of ipeca cuanha, charcoa
l and intravenous fluids allowed a rapid, successful outcome. This cas
e illustrates the particular features of CV 205-502 intoxication when
compared to other dopamine agonists, pointing out the tolerance of the
drug which can be considered for wider indications and safer prescrip
tions.